ClearMTB Therapeutics is a Danish research-driven biotechnology company developing therapeutic platforms across side-effect therapeutics, cell engineering and microbiome-based medicine.
We operate through a platform-based research model in which biological mechanisms are formalized as therapeutic frameworks. These frameworks can subsequently be translated into concrete treatment programs or strategic partnerships with larger biotechnology and pharmaceutical companies.
Our goal is to identify underexplored biological opportunities and develop them into structured therapeutic platforms capable of supporting translational research and future clinical development.
ClearMTB Therapeutics develops research platforms across three primary therapeutic domains.
| Platform | Description |
|---|---|
Side-Effect Therapeutics | Development of treatment-enabling therapeutics designed to mitigate treatment-limiting adverse effects in existing and emerging drug classes, improving tolerability and enabling broader clinical use. |
Engineered Cellular & Microbiome Systems | Development of integrated biological and computational frameworks to design and optimize engineered cellular and microbiome-based systems with improved stability, persistence, and coordinated functional performance. These systems are intended to enable targeted and sustained modulation of biological pathways within complex physiological environments, supporting precise and durable therapeutic intervention strategies. |
Virtual Integrated Therapeutic Discovery Platform | Hathmere is building a virtual laboratory for therapeutic discovery, an integrated scientific intelligence designed to understand biology across molecular, cellular, and physiological systems. By combining global biomedical knowledge, mechanistic modeling, and causal reasoning, the platform explores disease mechanisms, generates testable hypotheses, and designs therapeutic strategies for complex diseases. Instead of focusing on isolated targets, Hathmere treats biology as an interconnected system, enabling systematic discovery of interventions that would otherwise remain hidden within biological complexity. |
New biological mechanisms, translated into therapeutic platforms
A small, dedicated team driving ClearMTB's therapeutic platforms forward from Fyn, Denmark.
CEO & Founder
VP Strategy & PR
Lead Researcher
Business Development Associate
Research Associate
Leader of Project Hathmere
We seek collaboration with organizations that share our ambition to develop the next generation of therapeutic platforms.
Joint research projects and knowledge exchange within our platform domains. We actively seek academic partnerships to strengthen the scientific foundation of our frameworks.
Strategic partnerships for development and validation of new therapeutic frameworks. We are designed to work with partners who can bring these platforms through clinical development.
Translating research findings into clinically relevant programs and treatments. We bridge the gap between biological insight and therapeutic application.